BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6729079)

  • 1. The detection of ovarian cancer using 123J monoclonal antibody.
    Granowska M; Britton KE; Shepherd J
    Radiobiol Radiother (Berl); 1984; 25(1):153-60. PubMed ID: 6729079
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours.
    Granowska M; Mather SJ; Jobling T; Naeem M; Burchell J; Taylor-Papadimitriou J; Shepherd J; Britton KE
    Int J Biol Markers; 1990; 5(2):89-96. PubMed ID: 2283483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findings.
    Granowska M; Shepherd J; Britton KE; Ward B; Mather S; Taylor-Papadimitriou J; Epenetos AA; Carroll MJ; Nimmon CC; Hawkins LA
    Nucl Med Commun; 1984 Aug; 5(8):485-99. PubMed ID: 6533499
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody.
    Crippa F; Buraggi GL; Di Re E; Gasparini M; Seregni E; Canevari S; Gadina M; Presti M; Marini A; Seccamani E
    Eur J Cancer; 1991; 27(6):724-9. PubMed ID: 1829912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a model system to evaluate methods for radiolabeling monoclonal antibodies.
    Otsuka FL; Welch MJ; McElvany KD; Nicolotti RA; Fleischman JB
    J Nucl Med; 1984 Dec; 25(12):1343-9. PubMed ID: 6502256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [REGAJ diagnosis of recurrence of ovarian cancer].
    Paterok EM; Jäger W; Feistel H; Lang N; Wolf F
    Gynakol Rundsch; 1989; 29 Suppl 2():360-3. PubMed ID: 2613050
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies.
    Malamitsi J; Skarlos D; Fotiou S; Papakostas P; Aravantinos G; Vassilarou D; Taylor-Papadimitriou J; Koutoulidis K; Hooker G; Snook D
    J Nucl Med; 1988 Dec; 29(12):1910-5. PubMed ID: 3193206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunodiagnosis of ovarian cancer using 123I-labelled, tumor-associated monoclonal antibodies.
    Epenetos AA; Shepherd J; Britton KE; Hawkins L; Nimmon CC; Taylor-Papadimitriou J; Durbin H; Malpas JS; Mather S; Granowska M
    Cancer Detect Prev; 1984; 7(1):45-9. PubMed ID: 6367983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implications of patient antibody response for the clinical usefulness of immunoscintigraphy.
    Perkins AC; Pimm MV; Powell MC
    Nucl Med Commun; 1988 Apr; 9(4):273-82. PubMed ID: 3399224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody imaging of colorectal and ovarian cancer.
    Haseman MK
    West J Med; 1994 Oct; 161(4):412. PubMed ID: 7817555
    [No Abstract]   [Full Text] [Related]  

  • 11. A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer.
    Granowska M; Britton KE; Shepherd JH; Nimmon CC; Mather S; Ward B; Osborne RJ; Slevin ML
    J Clin Oncol; 1986 May; 4(5):730-6. PubMed ID: 3701391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 123I radioiodinated antibody imaging of occult ovarian cancer.
    Epenetos AA; Shepherd J; Britton KE; Mather S; Taylor-Papadimitriou J; Granowska M; Durbin H; Nimmon CC; Hawkins LR; Malpas JS
    Cancer; 1985 Mar; 55(5):984-7. PubMed ID: 3881163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour localisation with monoclonal antibody radioactivity labelled with metal chelate rather than iodine.
    Rainsbury R; Westwood J
    Lancet; 1982 Dec; 2(8311):1347-8. PubMed ID: 6128634
    [No Abstract]   [Full Text] [Related]  

  • 14. [Visualization of malignant tumors in the abdomen using radiolabelled monoclonal antibodies].
    Pateisky N; Philipp K; Burchell J; Skodler W
    Geburtshilfe Frauenheilkd; 1984 Oct; 44(10):623-6. PubMed ID: 6097499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies in ovarian tumor imaging.
    Fotiou S; Skarlos D; Tserkezoglou A; Aravantinos G; Malamitsi J; Koutoulidis K
    Eur J Gynaecol Oncol; 1988; 9(4):304-7. PubMed ID: 3391206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeled monoclonal antibodies for the diagnosis and treatment of ovarian carcinoma.
    Wahl RL
    Front Radiat Ther Oncol; 1990; 24():228-39. PubMed ID: 2187760
    [No Abstract]   [Full Text] [Related]  

  • 17. The development and use of radiolabeled antitumor antibodies.
    Pressman D
    Cancer Res; 1980 Aug; 40(8 Pt 2):2960-4. PubMed ID: 6994879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early results of the monoclonal antibody OVTL3 in specific detection of ovarian cancer.
    Epenetos AA; Lavender JP; Kenemans P; Poels L
    J Clin Oncol; 1987 Jan; 5(1):160. PubMed ID: 3806157
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy.
    Granowska M; Nimmon CC; Britton KE; Crowther M; Mather SJ; Slevin ML; Shepherd JH
    J Nucl Med; 1988 May; 29(5):599-607. PubMed ID: 3373302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary diagnosis and follow-up of ovarian cancer: radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and "second look".
    Barzen G; Hierholzer J; Cordes M; Friedmann W; Felix R
    Int J Rad Appl Instrum B; 1991; 18(1):69-76. PubMed ID: 2010310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.